Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.69 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.61 |
| ▸ | POLB | P06746 | 1/20 | 0.61 |
| ▸ | NPC1 | O15118 | 3/20 | 0.61 |
| ▸ | RAB9A | P51151 | 3/20 | 0.61 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.61 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.56 |
| ▸ | SMYD3 | Q9H7B4 | 1/20 | 0.56 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.54 |
| ▸ | KAT6A | Q92794 | 1/20 | 0.52 |
| ▸ | ERN1 | O75460 | 1/20 | 0.52 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.51 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.51 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.51 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.51 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.51 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12228078 | 0.89 | SMN1; SMN2 (0.57) | L3MBTL1SMN1; SMN2ALDH1A1POLBNPC1 | |
| SCHEMBL9490800 | 0.89 | HDAC3 (0.66) | L3MBTL1SMN1; SMN2NPC1RAB9ALMNA | |
| SCHEMBL16906909 | 0.89 | L3MBTL1 (0.67) | L3MBTL1SMN1; SMN2ALDH1A1POLBNPC1 | |
| SCHEMBL14233690 | 0.89 | L3MBTL1 (0.67) | L3MBTL1SMN1; SMN2ALDH1A1POLBNPC1 | |
| SCHEMBL13763531 | 0.88 | L3MBTL1 (0.80) | L3MBTL1SMN1; SMN2ALDH1A1POLBNPC1 | |
| SCHEMBL24527070 | 0.87 | HDAC3 (0.58) | L3MBTL1SMN1; SMN2NPC1RAB9AROCK2 | |
| SCHEMBL24904322 | 0.87 | SMN1; SMN2 (0.55) | L3MBTL1SMN1; SMN2ALDH1A1POLBNPC1 | |
| SCHEMBL17033996 | 0.87 | L3MBTL1 (0.65) | L3MBTL1SMN1; SMN2ALDH1A1POLBNPC1 | |
| SCHEMBL9691071 | 0.86 | KAT6A (0.55) | L3MBTL1SMN1; SMN2NPC1RAB9ASMYD3 | |
| SCHEMBL1928096 | 0.86 | NPC1 (0.65) | L3MBTL1SMN1; SMN2ALDH1A1POLBNPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2018118829-A1 | HETEROCYCLIC COMPOUNDS AS HIV PROTEASE INHIBITORS | MERCK SHARP & DOHME CORP. (US) | 2018-06-28 | — | — | WO | disclosed |
| US-20160362414-A1 | MACROCYCLES AS FACTOR XIA INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2016-12-15 | — | — | US | disclosed |
| US-9079918-B2 | Macrocycles as factor XIa inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2015-07-14 | — | — | US | disclosed |
| US-20140343276-A1 | MACROCYCLES AS FACTOR XIA INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2014-11-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140343276-A1 | MACROCYCLES AS FACTOR XIA INHIBITORS | TFPI, TFPI2, F11 | L3MBTL1 4750/4885SMN1; SMN2 3689/4885ALDH1A1 4598/4885 |
| US-20160362414-A1 | MACROCYCLES AS FACTOR XIA INHIBITORS | TFPI, TFPI2, F11 | L3MBTL1 4750/4885SMN1; SMN2 3689/4885ALDH1A1 4598/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.